Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

INDUSTRY 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 5Lymphoid 4Gastrointestinal 4Tumor-Agnostic 3Other hematologic neoplasm 3Genitourinary 3Thoracic 2Plasma cell 2Other neoplasm 2Other 2Dermatologic 2Myeloid 1Gynecologic 1CNS 1Breast 1

Conditions

Neoplasms 2Neoplasm Metastasis 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Radiosurgery 27Blood Specimen Collection 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Oxycodone × Tumor-Agnostic × Clear all
NCT04194528 2023-06-27

S1916 Digital Medicine Program for Pain Control in Cancer Patients

SWOG Cancer Research Network

Phase NA Terminated
2 enrolled 5 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT03564548 2021-07-28

REBORN

Tetra Bio-Pharma

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasms

NCT01675531 2016-12-16

A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Mundipharma Korea Ltd

Phase 4 Completed
73 enrolled 11 charts
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡